Ali Behbahani

VCInvestor

General Partner at New Enterprise Associates (NEA)

Current Investing Position

Investment Range

$2.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

$6.2B

Ali Behbahani is on these Sector & Stage Rankings

Ali Behbahani's Investments On Record (12)

Company	StageDateRound Size	Total Raised
Tune Therapeutics	Series BJan 2025$180M Series ADec 2021$40M	$220M
858 Therapeutics	Series BSep 2024$50M Series ASep 2021$60M	$110M
Co-investors: Clare Ozawa (Versant Ventures)
Amber Therapeutics	Series AJun 2024$100M	$100M
Co-investors: Tiffany Le (New Enterprise Associates (NEA)), Kevin Chu (F-Prime Capital Partners), Caroline Gaynor (Lightstone Ventures)
Nexo Therapeutics	Series AJul 2023$60M	$60M
Co-investors: Carlo Rizzuto (Versant Ventures)
Launchpad Therapeutics	Series ADec 2022$30M	$30M
Co-investors: Alexander Mayweg (Versant Ventures)
Stablix	Series AJun 2021$63M	$63M
Co-investors: Carlo Rizzuto (Versant Ventures)
Monte Rosa Therapeutics	Series CMar 2021$95M Series BSep 2020$96M Series AMay 2020$33M	$220M
Co-investors: Markus Warmuth (Versant Ventures), Alexander Mayweg (Versant Ventures), Chandra Leo (Hbm Partners), Andrew Schiff (Aisling Capital)
Spyglass Ophthalmics	Series BJan 2021$28M Series AMay 2019	$28M
Co-investors: Tak Cheung (New Enterprise Associates (NEA)), Cynthia Yee (Vensana Capital)